TEVA241101C22500
- 0.00
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today
Medincell Announces Participation in Leading Investor Conferences
XRP Dips as Ripple Co-Founder Larsen Donates $10 Million to Harris Campaign Amidst Next Gen Crypto Surge
Harris And Trump Still Neck-And-Neck As Race Enters Final Stretch
Ten Days Out, Democrats Fear Harris Is Falling Behind
Investors in Teva Pharmaceutical Industries (NYSE:TEVA) Have Seen Impressive Returns of 120% Over the Past Year
Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know
Ripple CEO Brad Garlinghouse Expects Crypto Reset, Will It Happen After US Elections?
Nate Silver's 'Gut' Says Trump Will Win, But Kamala Harris 'Could Beat Her Polls': One Trader Bets Over $3 Million She Does
Unusual Options Activity: TEVA, MRVL and Others Attract Market Bets, TEVA V/OI Ratio Reaches 1692.3
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $25
Teva Pharmaceutical (TEVA) Receives a Buy From Barclays
Bill Gates Makes $50M Private Donation To Kamala Harris' Campaign After Years Of Political Silence: 'This Election Is Different,' Says Billionaire
Co-founder Chris Larsen Donates '$10M in XRP' to Kamala Harris' Campaign
Trump Vs. Harris: Vice President Holds Slim Lead, Losing Momentum In Key Demographics, Favorability After Media Blitz
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
Teva, Alvotech Get Expanded FDA Approval for Stelara Biosimilar
Express News | Alvotech, Teva Reports FDA Approval For SELARSDI (Ustekinumab-aekn) In New Presentation, 130 Mg/26 Ml (5 Mg/Ml) Solution In Single-dose Vial For Intravenous Infusion
Express News | Teva Pharmaceutical Industries Ltd - Selarsdi U.S. Launch Expected in Q1 2025